Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Study Information
Alliance Study ID: CALGB-10003
NCT Study ID (ClinicalTrials.gov): NCT00031980
Alliance Committee: Leukemia
Disease or Cancer Type: Hematologic Malignancies (General / Unspecified)
Alliance Study Chair: Maria R. Baer, MD
Status: COMPLETED
Study Description
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic cancer.
PURPOSE: Phase II trial to study the effectiveness of cyclosporine in treating patients who have low blood counts caused by hematologic cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information